Genetic variation in resistance of turkeys to experimental challenge with Pasteurella multocida.

Six hundred fifty-five male and female turkeys representing four genetic lines were challenged in 10 experiments over a 3-year period with a field isolate of Pasteurella multocida. Poults were challenged at 45 days of age with 1 ml of an inoculum containing 1.2 x 10(7) bacteria per ml. The lines of turkeys included two randombred control lines (RBC1 and RBC2), a subline (E) of RBC1 selected for increased egg production, and a subline (F) of RBC2 selected for increased 16-week body weight. The number of days from exposure to severe clinical signs or death for Line F (5.8 days) differed significantly from that of Line E (8.2 days), Line RBC1 (8.0 days), and Line RBC2 (8.2 days). There were no significant differences due to sex of poult for number of days from exposure to severe clinical signs or death. Overall mortality observed was 51.2%. Mortality was highest for Line F (72.1%) and differed significantly from that of the other lines. Mortality among male poults did not differ significantly from mortality among female poults.     

Genetic variation in response of turkeys to experimental infection with Bordetella avium

One hundred ninety-six male and female turkeys representing two genetic lines were experimentally infected with Bordetella avium. The lines of turkeys included a randombred control line (RBC2) and a subline (F) of RBC2 selected for increased 16-wk body weight. No difference was found between lines RBC2 and F in the number of days to onset of clinical signs, and no mortality due to B. avium infection was observed in either line. Interestingly, however, a significant depression (12%) occurred in body weight of F line poults infected with B. avium, but no significant depression occurred in body weight of RBC2 poults.     

Genetic variation in resistance of turkeys to experimental infection with Newcastle disease virus.

Seven hundred eighty male and female turkeys representing four genetic lines were challenged in four experiments with the Texas GB strain of Newcastle disease virus (NDV). The lines of turkeys included two randombred control lines (RBC1 and RBC2), a subline (E) of RBC1 selected for increased egg production, and a subline (F) of RBC2 selected for increased 16-week body weight. Mortality in turkeys of subline F (32.5%) was significantly higher than that in turkeys of line RBC2 (15.8%), subline E (17.5%), and line RBC1 (18.4%). At the end of each experiment, surviving birds were tested for antibody to NDV using the enzyme-linked immunosorbent assay (ELISA) and hemagglutination-inhibition (HI) test. Turkeys of subline E and line RBC1 had significantly lower ELISA antibody titers than those of subline F and line RBC2. Subline F had the highest HI antibody titers, followed in decreasing order by lines RBC2 and RBC1 and subline E. No apparent correlation was found between antibody response and mortality after NDV challenge.     

Antibody response and resistance of turkeys to Newcastle disease vaccine strain LaSota.

Studies were undertaken to determine the influence of repeated revaccination on the immune response in immuno-competent turkeys as measured by humoral antibody and resistance to challenge. Protection was better in turkeys given the LaSota spray vaccine at 4 weeks and 30 days later than in turkeys given one vaccination by spray or intramuscular route or exposed 4 times at 10-day intervals by the aerosol route. The anamnestic response, as measured by the HI tests to revaccination with the same immunogen, was not evident by the 3rd day postrevaccination but was observed on the 7th day. The interval between primary and secondary vaccination was found to be important to a true and optimal anamnestic response. Response was greater, however, in vaccinated turkeys exposed to VVND, a more virulent virus antigenically different from the vaccine strain. Exposure to LaSota vaccine by the intramuscular route gave a poorer HI response than LaSota given by aerosol.     

新城疫LaSota活疫苗对基因Ⅶ型分离株的免疫保护性试验

从山东省发病鸡群分离鉴定了一株新城疫病毒(NDV),命名为SDLY01。经蚀斑纯化后进行毒力测定和序列分析表明分离株SDLY01属于基因Ⅶ型NDV强毒。20只7日龄SPF鸡免疫新城疫活疫苗LaSot a后14 d分别用NDV标准强毒F48E8和分离株SDLY01攻毒,同时设同日龄SPF鸡为对照组,未免疫任何疫苗。攻毒后观察10 d,免疫组在攻毒后食欲、精神均正常;对照组在攻毒后2～4d发病死亡,并表现ND典型的临床症状和病理变化。攻毒后第3、5、7、9 d对免疫组试验鸡取喉头、泄殖腔棉拭进行病毒分离,F48E8攻毒组病毒分离均为NDV阴性,SDLYO1攻毒组第5 d病毒分离NDV阳性,第3、7和9d病毒分离阴性。本研究结果表明LaSot a活疫苗对F48E8和SDLY01均能提供100%免疫保护,但不能完全抑制基因Ⅶ NDV分离株在体内的复制和排毒。     

鸡传染性法氏囊病CH80活疫苗免疫效果研究

试验用鸡传染性法氏囊病CH80活疫苗和某进口鸡传染性法氏囊活疫苗分别免疫18 000 AA肉鸡,于免疫前1d,免疫后14d,31d分别检测IBD抗体和新城疫HI抗体;免疫后4d观察法氏囊病理变化并测定囊重指数;出栏时(45日龄),计算成活率、体重、料肉比及生产指数等。结果表明,CH80活疫苗免疫后,抗体水平略高于对照组,并可一直维持到肉鸡出栏;对法氏囊的损伤也明显小于对照组;对新城疫HI抗体没有明显的影响;总体经济效益也略高于对照组。     

Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens,and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV

A Newcastle disease virus (NDV) isolate designated IBS002 was isolated from a commercial broiler farm in Malaysia. The virus was characterised as a virulent strain based on the multiple basic amino acid motif of the fusion (F) cleavage site ¹¹²RRRKGF¹¹⁷ and length of the C-terminus extension of the hemagglutinin-neuraminidase (HN) gene. Furthermore, IBS002 was classified as a velogenic NDV with mean death time (MDT) of 51.2 h and intracerebral pathogenicity index (ICPI) of 1.76. A genetic distance analysis based on the full-length F and HN genes showed that both velogenic viruses used in this study, genotype VII NDV isolate IBS002 and genotype VIII NDV isolate AF2240-I, had high genetic variations with genotype II LaSota vaccine. In this study, the protection efficacy of the recombinant genotype VII NDV inactivated vaccine was also evaluated when added to an existing commercial vaccination program against challenge with velogenic NDV IBS002 and NDV AF2240-I in commercial broilers. The results indicated that both LaSota and recombinant genotype VII vaccines offered full protection against challenge with AF2240-I. However, the LaSota vaccine only conferred partial protection against IBS002. In addition, significantly reduced viral shedding was observed in the recombinant genotype VII-vaccinated chickens compared to LaSota-vaccinated chickens.     

Preliminary testing in turkeys of the safety and efficacy of a putative haemorrhagic enteritis virus vaccine

Haemorrhagic enteritis virus (HEV) causes clinical haemorrhagic enteritis in young poults and/or subclinical immunosuppression which is often associated with colibacillosis. This disease is controlled with live vaccines worldwide, however, importation of HEV vaccines or cells that support HEV propagation are not permitted in Australia. A major experiment in isolators was conducted to test the safety and efficacy of a putative HEV vaccine. The study had a factorial design with four factors namely vaccination age (28 and 42 days of age), vaccine dose (0, 10⁵, 10⁶, 10⁷ genomic copies of HEV vaccine), challenge with HEV (yes, no) and vaccination‐challenge interval (7, 21 or 42 days). A total of 315 poults were used providing 6‐8 birds per treatment combination. Turkey growth rate, mortality, pathological findings, anti‐HEV antibodies and viral load were examined. Vaccination lead to significant increases in anti HEV antibody over the following 2‐4 weeks. Overall, vaccination with 10⁶ and 10⁷ was protective against increase in relative splenic weight and splenic viral load in challenged birds. Clinical haemorrhagic enteritis was not induced by any treatment but there was an increased incidence of airsacculitis in groups receiving either HEV vaccine or challenge virus compared to the negative control birds (25.8‐29.3% vs. 9.4%, P < 0.05). Growth rate, mortality and relative bursal weight were unaffected by vaccination. This laboratory level study indicates that the putative vaccine is safe and likely to be efficacious, but may cause elevated levels of airsacculitis. These findings require confirmation in larger scale field trials.     

Direct and maternal genetic differences between lines of mice selected for body weight and litter size: traits of dams

Genetic differences in performance of dams were estimated by linear contrasts using means of two selected lines of mice and reciprocal F1's, F2's and backcrosses. The lines were selected for increased 6-wk body weight (W) or increased litter size (L). Genetic differences estimated were direct average (gD), direct heterosis (hD), maternal average (gM), progeny average (gP), and progeny heterosis (hP). For dam weight and feed consumption from 12 to 21 d postpartum (pp), gD was the largest genetic difference and favored line W. For litter size, litter weight at birth, litter efficiency (litter weight gain/dam feed consumption) from birth to 12 d pp and within litter mortality from 1 to 21 d pp, gD favored L and, except for hD in litter efficiency, was the most important genetic difference for these traits. Direct heterosis was the only significant difference for litter weight at 21 d pp, litter efficiency from 12 to 21 d pp and within litter mortality at parturition. The gM were larger in W than in L for dam weight and feed consumption, and for litter size and weight at birth, but they were usually of smaller magnitude than gD. The gP were significant only in litter traits measured before 12 d pp and favored W. For no trait measured was hP of consequence. Line differences in dam and litter weight accounted for genetic differences in dam feed consumption. Genetic differences in litter size at birth were not due to line differences in dam weight. The lower mortality within litters nursed by crossbred dams was responsible for hD on litter weight and litter efficiency. Within but not among lines, higher mortality rates were associated with larger litters.     

Coarse-spray immunization of one-day-old broilers against enteric reovirus infections.

Coarse-spray (CS) administration of a commercial S1133 reovirus vaccine was evaluated in 1-day-old specific-pathogen-free broilers for prevention of clinical infection induced by intratracheal challenge with two enteric reovirus isolates. In Expt. 1, chickens were challenged at 4 days of age with either the 2408 or CO8 isolate. In Expt. 2, chickens were challenged at 7 days of age with either isolate. In Expt. 3, chickens were challenged at 3, 5, or 7 days of age with the 2408 isolate. In Expt. 1, vaccinated birds showed significant protection against challenge with either isolate at 4 days of age as measured by morbidity, mortality, gross lesions, and body weight. In Expt. 2, vaccinated birds showed greater protection against challenge at 7 days of age. In Expt. 3, resistance in vaccinated birds increased with time between vaccination and challenge. Vaccinated birds challenged at 3 days of age showed no significant protection, whereas vaccinated birds challenged at 5 or 7 days of age had increased resistance. This vaccine did not induce a drop in weight gain, morbidity, mortality, or microscopic lesions in the tendons.     

猪脾转移因子提高LaSota株鸡新城疫弱毒疫苗的免疫保护率

旨在了解猪脾转移因子（TF）对新城疫病毒（NDV）弱毒疫苗LaSota株的免疫增强效果及机制。本研究分别采用不同剂量（10^-2、10^-3、10^-4、10^-5羽份） LaSota疫苗株单独（单独免疫组）、LaSota疫苗株与TF联合（联合免疫组）免疫SPF鸡,14 d后以NDV F₄₈E₉强毒攻毒,同时设立对照组（非免疫攻毒）和空白组（非免疫非攻毒）,并采用ELISA方法与蛋白质芯片技术分别测定外周血IL-4、IFN-γ与IL-12 P40浓度。结果显示,鸡免疫10^-2、10^-3、10^-4、10^-5羽份时疫苗攻毒保护率和半数保护量（PD₅₀）如下：单独免疫组分别为100%、55%、0%、0%和0.000 8羽份,联合免疫组分别为100%、75%、0%、0%和0.000 5羽份,对照组和空白组死亡率分别为100%和0%。免疫10^-3羽份疫苗后,联合免疫组IL-4和IFN-γ含量均高于其他组,并于第7、14天差异极显著（P<0.01）;攻毒后,联合免疫组IL-4、IFN-γ和IL-12 P40含量均高于其他组,IL-4于第1、14天,IFN-γ于第1、3天,IL-12 P40于第1天差异极显著（P<0.01）。综上表明,TF可增强IFN-γ、IL-12介导的细胞免疫和IL-4介导的体液免疫,提高LaSota株弱毒疫苗的免疫保护率,降低疫苗PD₅₀;在抵抗NDV F₄₈E₉强毒攻击时,联合免疫组的免疫保护率明显高于单独免疫组。     

Rates of muscle protein breakdown in chickens selected for increased growth rate, food consumption or efficiency of food utilisation as assessed by N tau-methylhistidine excretion

1. N tau-methylhistidine excretion, growth rate, food consumption and body composition was determined in 12 4 to 5 week old chickens sampled from each of 4 lines selected for increased body-weight gain (line W), for increased food consumption (line F), for improved efficiency of food utilisation (line E) or at random (line C), after 12 generations of selection. 2. The use of N tau-methylhistidine as an index of myofibrillar protein breakdown was validated in male and female chickens of lines E and F by following the fate of injected N tau-(14CH3)methylhistidine. Most of the radioactivity (79.3 +/- 1.1%) was excreted in 4 d, with the remainder retained in the carcase. In excreta, 94 +/- 2% of the radioactivity was associated with free N tau-methylhistidine and for the carcase, this value was 88 +/- 3%. 3. In the main experiment, final body weights averaged 497, 651, 588 and 537 g and food: gain ratio averaged 2.47, 2.21, 3.14 and 2.06 for lines C, W, F and E respectively, Carcase protein content (g/100 g body weight) was not different between the lines. 4. N tau-methylhistidine excretion was 5.86, 5.48, 6.43 and 4.99 mumoles/mole carcase-N/d for lines C, W, F and E, respectively. The rate for line F was significantly higher than for lines W and C and that for line E was significantly less than for the control line. 5. The N tau-methylhistidine excretion rate was positively correlated with food: gain ratio. 6. Selection for rapid growth, high food consumption or improved food utilisation results in changes in N tau-methylhistidine excretion which suggest proportionate changes in muscle protein turnover.     

Antibody response of kori bustards (Ardeotis kori) and houbara bustards (Chlamydotis undulata) to live and inactivated Newcastle disease vaccines.

Adult houbara bustards (Chlamydotis undulata) and juvenile kori bustards (Ardeotis kori) were given four regimens of commercially available inactivated and live poultry paramyxovirus type 1 (PMV-1) vaccines. Immunologic response to vaccination was assessed by hemagglutination inhibition assay of serum. Kori bustards, to which a dose of 0.5 ml of a commercially available inactivated vaccine for poultry had been administered intramuscularly (0.15 ml/kg body weight), failed to develop hemagglutinating antibodies, but antibody titers of low intensity and duration were detected following administration of a second and third subcutaneous dose of 2.0 ml vaccine per bird (0.40-0.45 ml/kg). In subsequent trials, when inactivated vaccine was administered subcutaneously at 1.0 ml/kg body weight following two or four live vaccinations administered by the ocular route, juvenile kori bustards developed higher, more persistent titers of antibodies. Kori bustards given four live vaccinations followed by inactivated vaccine developed higher titers of longer duration compared with kori bustards given two live vaccines followed by inactivated vaccine. Antibody titers of kori bustards given inactivated vaccine were higher and more persistent than the antibody response to live vaccination. Houbara bustards, previously vaccinated with inactivated vaccine, that were given a booster dose of inactivated vaccine maintained high mean antibody titers (> or = log, 5) for 52 wk. The authors recommend that inactivated PMV-1 vaccine should be administered by subcutaneous injection of 1.0 ml/kg vaccine to bustards. Adult bustards, previously vaccinated with inactivated vaccine, should be vaccinated annually with inactivated vaccine. Juvenile bustards should receive a second dose of inactivated vaccine 4-6 mo after the first dose of inactivated vaccine. Even though inactivated PMV-1 vaccines induced hemagglutination inhibition antibodies and produced no adverse reactions, further studies will be required to determine the protective efficacy of the antibody.     

Adverse events diagnosed within three days of vaccine administration in dogs

OBJECTIVE: To determine incidence rates and potential risk factors for vaccine-associated adverse events (VAAEs) diagnosed within 3 days of administration in dogs. DESIGN: Retrospective cohort study. ANIMALS: 1,226,159 dogs vaccinated at 360 veterinary hospitals. PROCEDURE: Electronic records from January 1, 2002, through December 31, 2003, were searched for possible VAAEs (nonspecific vaccine reaction, allergic reaction, urticaria, or anaphylaxis) diagnosed within 3 days of vaccine administration. Information included age, weight, sex, neuter status, and breed. Specific clinical signs and treatments were reviewed in a random sample of 400 affected dogs. The association between potential risk factors and a VAAE was estimated by use of multivariate logistic regression. RESULTS: 4,678 adverse events (38.2/10,000 dogs vaccinated) were associated with administration of 3,439,576 doses of vaccine to 1,226,159 dogs. The VAAE rate decreased significantly as body weight increased. Risk was 27% to 38% greater for neutered versus sexually intact dogs and 35% to 64% greater for dogs approximately 1 to 3 years old versus 2 to 9 months old. The risk of a VAAE significantly increased as the number of vaccine doses administered per office visit increased; each additional vaccine significantly increased risk of an adverse event by 27% in dogs < or = 10 kg (22 lb) and 12% in dogs > 10 kg. CONCLUSIONS AND CLINICAL RELEVANCE: Young adult small-breed neutered dogs that received multiple vaccines per office visit were at greatest risk of a VAAE within 72 hours after vaccination. These factors should be considered in risk assessment and risk communication with clients regarding vaccination.     

Serological responses of farmed red deer to a vaccine against Leptospira interrogans serovars hardjo and pomona

Six adult, female, red deer were vaccinated with a hardjo-pomona vaccine followed by a second vaccination four weeks later and thereafter, at yearly intervals for two years. Serological responses were determined at intervals using a standard microscopic agglutination test. Increased responses to hardjo were observed in two deer which were seropositive to this serovar before vaccination compared to those which were initially seronegative. Some initially seronegative deer developed titres to hardjo and pomona ranging from 1:24 to 1:48 following the first dose of vaccine, and all deer produced a serological response to both serovars ranging from 124 to 1:96 following the second vaccination except one animal which failed to produce a pomona titre of 124 or greater. Responses to annual revaccinations were more variable both within and between years. Most deer produced titres which ranged from 1:24 to 1:96 for three to live months, although some deer failed to seroconvert following the annual revaccinations. Peak responses were similar to those recorded in cattle following an identical vaccination programme with the same vaccine but titres fell to undetectable levels after three to live months whereas titres reported in cattle generally persisted for at least 12 months.     

一株Class Ⅰ新城疫病毒中国分离株分子特性的研究

对从健康家鸭中分离到的一株Class I新城疫病毒分离株Duck/China/08-004/2008进行了遗传进化特性研究。利用RT-PCR扩增了该分离株F基因的主要功能区片段,并进行了克隆与序列分析。序列测定结果已经登录到GenBank,登录号为EU589149。该分离株F蛋白裂解位点的组成为112E-Q-Q-E-R-L117,具有典型新城疫弱毒株的分子特征。同源性分析表明其与国内普遍使用的弱毒疫苗株LaSota和V4核苷酸的同源性较低(分别为55.4%和57.7%)。通过构建F基因的遗传进化树,结果表明该分离株在分类地位上属于ClassI,与我国目前普遍使用的弱毒疫苗株LaSota(Class II中的基因II型)和V4(Class II中的基因I型)处在不同的进化分支。通过构建57株ClassI新城疫病毒的遗传进化树,表明本分离株与近年来香港活禽市场分离株较为类似,同属于基因3型。     

Evaluation of antibody response and nonspecific lymphocyte blastogenesis following inoculation of a live attenuated bluetongue virus vaccine in goats

OBJECTIVE: To evaluate vaccine safety, antibody response, and nonspecific lymphocyte blastogenesis following inoculation of a commercial monovalent live attenuated bluetongue virus (BTV) serotype 2 vaccine in goats. ANIMALS: 12 nonpregnant and nonlactating Saanen goats. PROCEDURE: 6 goats were inoculated with the monovalent live attenuated BTV serotype 2 vaccine, which has been widely used in Italy during the proceding 2 years. The other 6 goats were unvaccinated and represented negative controls. Nonspecific lymphocyte blastogenesis was evaluated 14 and 7 days before and 7, 21, and 49 days after vaccination by measuring DNA synthesis in peripheral blood mononuclear cells (PBMCs) stimulated with phytohemagglutinin, concanavalin-A, and pokeweed mitogen. On the same days as lymphocyte blastogenesis, blood samples were taken to determine serum concentrations of anti-BTV antibodies. RESULTS: During the 7 weeks following vaccination, PBMCs obtained from vaccinated goats had a significantly decreased response to mitogens in terms of DNA synthesis, compared with PBMCs from the same goats before vaccination. Conversely during the experiment, no significant change was found in the response of the PBMCs obtained from unvaccinated goats. Starting from 21 days after vaccination, serum from vaccinated goats had anti-BTV antibodies. No anti-BTV antibodies were detected in the serum from unvaccinated goats. CONCLUSIONS AND CLINICAL RELEVANCE: Inoculation of goats with the monovalent live attenuated BTV serotype 2 vaccine described herein resulted in a profound depression of nonspecific lymphocyte blastogenesis, which might compromise the resistance of vaccinated goats to pathogens.     

The potential role of an inactivated thermostable vaccine in the control of Newcastle disease in traditionally free-roaming poultry in Central and West Africa

In spite of the clinical and economic importance of Newcastle disease (ND), vaccination of traditional poultry flocks is not a common practice in Cameroon and other countries in West and Central Africa. This study was designed to demonstrate the importance of vaccination against ND and to propose a sustainable vaccination programme with a LaSota strain of NDV vaccine (Multivax) produced in Cameroon. It consisted of field vaccination trials, determination of a strategic vaccination programme through sero-monitoring and assessing vaccine keeping quality under field conditions. Twelve months monitoring of vaccinated flocks revealed that the epidemic periods of March–April and December–January passed without major incidence in flocks. Mortalities were reduced from above 90% in previous years to 10.8% and 24.6% in two experimental sites respectively. Vaccination antibodies were sustained above protection threshold for about 80 days. A booster administered 35 days after the priming dose did not have any effect on declining serum antibodies. The vaccine remained efficacious in eliciting antibody production for up to 10 weeks after initial use and kept at ambient temperature averaging 34°C. For good protection in a less intense vaccination programme, it would be necessary to administer the vaccine one month to the anticipated month of epidemic, thus requiring at least two campaigns per year.     

Postpartum performance in a diallel cross among lines of mice selected for litter size and body weight

Postpartum dam performance was studied in a complete diallel design involving five lines of mice. The selection criterion in each line was: large litter size at birth (L+); large 6-wk body weight (W+); an index for large litter size and small 6-wk body weight (L+W-); the complementary index (L-W+) and random (K). Females from the five lines and 20 reciprocal F1 crosses were mated to sires of a randomly selected control line (CC). Correlated responses in average direct genetic and average maternal genetic effects for dam body weight and litter size at parturition persisted throughout lactation, indicating important pleiotropic effects. Major correlated responses occurred for litter weight, feed intake and litter feed efficiency, primarily due to average direct genetic effects. Using general combining ability and net line effects as criteria for choosing among lines, L+ had a distinct advantage if the objective was to increase litter size in a crossing program. If the objective was to maximize litter weaning weight, then W+ would be favored for net line effects, while L+ and W+ would be about equivalent for general combining ability. None of the lines had an advantage for litter feed efficiency. Direct heterosis for dam weight at 12 and 21 d of lactation averaged 2.7 and 1.9%, while for litter size the respective averages were 7.4 and 7.3%. The W+ X L+W- cross exhibited overdominance for litter size. Direct heterosis was moderate for feed intake and litter weight, but was negligible for litter feed efficiency because of the mathematical relationship among the three traits. Maternal heterosis for preweaning progeny growth was suppressed because of heterosis for litter size in the dam. Grand-maternal effects on growth of the young were small and would not be an important consideration in choosing among these lines in a crossbreeding program.     

Increased mortality in mice infected with rabies virus and subsequently vaccinated against rabies

When mice infected 1 or 2 days before by an IM inoculation after high passage of the virus in the species ("challenge virus standard" strain) received an injection of live (Flury) or inactivated virus, their mortality was increased in comparison with unvaccinated controls. In the case of the inactivated virus vaccine, mortality was proportional to the dose of vaccine received. Conversely, when vaccination was carried out in mice recently infected with the same doses of a heterologous strain adapted to foxes, this phenomenon could not be demonstrated. The consequences of these observations on failures of treatment in animals infected with a homologous strain, cases of rabies occurring after vaccination or quality control of vaccines are discussed.